Ra Pharmaceuticals

Acquired

Cambridge, United States · Founded 2008

Employees
51–200
Founded
2008
Business Model
B2B
Last Round
Series BJul 2015
Rounds
3
Acquisition Date
Apr 2020

About

Ra Pharmaceuticals was a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics targeting the complement system to treat rare and severe diseases. The company's lead asset zilucoplan targeted generalized myasthenia gravis. Ra Pharmaceuticals was acquired by UCB for approximately $2.1 billion in April 2020.

Summary

Ra Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2008. Its most recent funding was a Series B round in Jul 2015. Investors include Lightstone Ventures, RA Capital Management and Novo Holdings A/S.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionApr 2020

Sign up to see all 5 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ra Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/ra-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/ra-pharmaceuticals" alt="Ra Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>